Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2020 1
2021 4
2022 8
2023 12
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

24 results

Results by year

Filters applied: . Clear all
Page 1
Japan Endocrine Society clinical practice guideline for the diagnosis and management of primary aldosteronism 2021.
Naruse M, Katabami T, Shibata H, Sone M, Takahashi K, Tanabe A, Izawa S, Ichijo T, Otsuki M, Omura M, Ogawa Y, Oki Y, Kurihara I, Kobayashi H, Sakamoto R, Satoh F, Takeda Y, Tanaka T, Tamura K, Tsuiki M, Hashimoto S, Hasegawa T, Yoshimoto T, Yoneda T, Yamamoto K, Rakugi H, Wada N, Saiki A, Ohno Y, Haze T. Naruse M, et al. Among authors: haze t. Endocr J. 2022 Apr 28;69(4):327-359. doi: 10.1507/endocrj.EJ21-0508. Epub 2022 Apr 12. Endocr J. 2022. PMID: 35418526 Free article.
LPIN1 is a new target gene for essential hypertension.
Fujiwara A, Ozawa M, Sumida K, Hirawa N, Yatsu K, Ichihara N, Haze T, Komiya S, Ohki Y, Kobayashi Y, Wakui H, Tamura K. Fujiwara A, et al. Among authors: haze t. J Hypertens. 2022 Mar 1;40(3):536-543. doi: 10.1097/HJH.0000000000003046. J Hypertens. 2022. PMID: 34772856
Associated factors and effects of comorbid atrial fibrillation in hypertensive patients due to primary aldosteronism.
Sakaguchi S, Okamoto R, Inoue C, Akao M, Kamemura K, Kurihara I, Takeda Y, Ohno Y, Inagaki N, Rakugi H, Katabami T, Tsuiki M, Tanabe A, Tamura K, Fujita S, Yano Y, Dohi K; JRAS investigators; Naruse M. Sakaguchi S, et al. J Hum Hypertens. 2023 Sep;37(9):757-766. doi: 10.1038/s41371-022-00753-2. Epub 2022 Sep 24. J Hum Hypertens. 2023. PMID: 36153382
Improved Immune Response to the Third COVID-19 mRNA Vaccine Dose in Hemodialysis Patients.
Kanai D, Wakui H, Haze T, Azushima K, Kinguchi S, Kanaoka T, Toya Y, Hirawa N, Kato H, Uneda K, Watanabe F, Hanaoka K, Hanaoka M, Mitsuhashi H, Yamaguchi S, Ohnishi T, Tamura K. Kanai D, et al. Among authors: haze t. Kidney Int Rep. 2022 Dec;7(12):2718-2721. doi: 10.1016/j.ekir.2022.09.005. Epub 2022 Sep 11. Kidney Int Rep. 2022. PMID: 36120389 Free PMC article. No abstract available.
Association of achieved blood pressure after treatment for primary aldosteronism with long-term kidney function.
Haze T, Yano Y, Hatano Y, Tamura K, Kurihara I, Kobayashi H, Tsuiki M, Ichijo T, Wada N, Katabami T, Yamamoto K, Okamura S, Kai T, Izawa S, Yoshikawa Y, Yamada M, Chiba Y, Tanabe A, Naruse M; JPAS/JRAS Study Group. Haze T, et al. J Hum Hypertens. 2022 Oct;36(10):904-910. doi: 10.1038/s41371-021-00595-4. Epub 2021 Aug 30. J Hum Hypertens. 2022. PMID: 34462544
SARS-CoV-2 spike protein antibody titers 6 months after SARS-CoV-2 mRNA vaccination among patients undergoing hemodialysis in Japan.
Kanai D, Wakui H, Haze T, Azushima K, Kinguchi S, Tsukamoto S, Kanaoka T, Urate S, Toya Y, Hirawa N, Kato H, Watanabe F, Hanaoka K, Hanaoka M, Mitsuhashi H, Yamaguchi S, Ohnishi T, Tamura K. Kanai D, et al. Among authors: haze t. Clin Exp Nephrol. 2022 Oct;26(10):988-996. doi: 10.1007/s10157-022-02243-8. Epub 2022 Jun 25. Clin Exp Nephrol. 2022. PMID: 35751753 Free PMC article.
24 results